Metis TechBio Co., Ltd. (HKG:7666)
Hong Kong · Delayed Price · Currency is HKD 17.60
+0.33 (1.91%)
May 28, 2026, 9:30 AM HKT
Metis TechBio Market Cap
Metis TechBio has a market cap or net worth of 19.9 billion as of May 27, 2026.
Market Cap
19.90B
Enterprise Value
18.80B
Revenue
116.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.60
Market Cap Chart
Since May 13, 2026, Metis TechBio's market cap has decreased from 27.43B to 19.90B, a decrease of -27.44%. That is a compound annual growth rate of -99.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 19.90B | 5.50% |
| May 26, 2026 | 18.87B | -3.02% |
| May 22, 2026 | 19.45B | 3.12% |
| May 21, 2026 | 18.87B | -9.06% |
| May 20, 2026 | 20.75B | -10.27% |
| May 19, 2026 | 23.12B | -14.13% |
| May 18, 2026 | 26.92B | 7.65% |
| May 15, 2026 | 25.01B | -14.03% |
| May 14, 2026 | 29.09B | 6.05% |
| May 13, 2026 | 27.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 28.38B |
| InnoCare Pharma | 24.94B |
| Duality Biotherapeutics | 20.12B |
| Keymed Biosciences | 18.50B |
| TransThera Sciences (Nanjing) | 17.31B |
| Ascletis Pharma | 16.56B |
| Zai Lab | 16.38B |
| Ascentage Pharma Group International | 15.33B |